H. C. Falkson
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Oncology top 5%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Cutaneous Melanoma Detection and Management
- Cancer Risks and Factors
Papers in
- Oncology 17
- Cancer Treatment and Pharmacology 10
- Colorectal Cancer Treatments and Studies 3
- Cancer Risks and Factors 2
-
- Breast Cancer Treatment Studies 8
- Co-authors
- Geoffrey Falkson (29 shared papers)Carla Isadora Falkson (6 shared papers)Douglass C. Tormey (2 shared papers)Rob Gray (2 shared papers)D C Tormey (4 shared papers)Johann Raats (1 shared paper)T. E. Davis (2 shared papers)Avital Cnaan (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Cancer (4 papers)Annals of Oncology (3 papers)The Lancet (2 papers)Cancer Treatment Reviews (2 papers)
- Partner nations
- South AfricaUnited StatesUnited Kingdom
In The Last Decade
H. C. Falkson
31 papers receiving 997 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 329
- Oncology 598
- Hepatology 86
- Genetics 255
- Pathology and Forensic Medicine 107
Countries citing papers authored by H. C. Falkson
This map shows the geographic impact of H. C. Falkson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. C. Falkson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. C. Falkson more than expected).
Fields of papers citing papers by H. C. Falkson
This network shows the impact of papers produced by H. C. Falkson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. C. Falkson. The network helps show where H. C. Falkson may publish in the future.
Co-authors
The 25 scholars most cited alongside H. C. Falkson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 161 | |
| 2 | 1991 | 152 | |
| 3 | 1975 | 93 | |
| 4 | Prognostic factors for survival in hepatocellular carcinoma. | 1988 | 87 |
| 5 | 1983 | 73 | |
| 6 | 1986 | 68 | |
| 7 | 1990 | 64 | |
| 8 | 1992 | 59 | |
| 9 | 1996 | 52 | |
| 10 | 1982 | 48 | |
| 11 | 1980 | 48 | |
| 12 | 1978 | 33 | |
| 13 | 1969 | 29 | |
| 14 | 1979 | 27 | |
| 15 | 1988 | 24 | |
| 16 | 1989 | 20 | |
| 17 | 1982 | 17 | |
| 18 | 1983 | 16 | |
| 19 | Hematological toxicity: experience with anthracyclines and anthracenes. | 1985 | 12 |
| 20 | 1965 | 8 |
About H. C. Falkson
H. C. Falkson is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Genetics, having authored 32 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Breast Cancer Treatment Studies (8 papers), Estrogen and related hormone effects (6 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Genetic factors in colorectal cancer (2 papers) and Cancer Risks and Factors (2 papers). The work is most often cited by research in Cancer Research (329 citations), Oncology (598 citations), Hepatology (86 citations), Genetics (255 citations) and Pathology and Forensic Medicine (107 citations). H. C. Falkson has collaborated with scholars based in South Africa, United States and United Kingdom. Frequent co-authors include Geoffrey Falkson, Carla Isadora Falkson, Douglass C. Tormey, Rob Gray, D C Tormey, Johann Raats, T. E. Davis, Avital Cnaan, Allan J. Schutt and LOUISE M. RYAN. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Annals of Oncology, The Lancet and Cancer Treatment Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.